chronic%20pelvic%20pain%20in%20women
CHRONIC PELVIC PAIN IN WOMEN
Chronic pelvic pain (CPP) is a persistent, distressing, and severe pain of >6-month duration.
It occurs intermittently, cyclically, or situationally.
Localized to the pelvis, anterior abdominal wall at or below the umbilicus, the lumbosacral back, or the buttocks.
In women, CPP is not restricted to intercourse or menstruation and is not associated with pregnancy.
A complex problem that is both multifactorial & multidimensional.

Chronic Pelvic Pain in Women Drug Information

Drug Information

Indication: Severe acute & chronic pain. Painful diagnostic or therapeutic measures.

Indication: Moderate to severe acute & chronic pain & in painful diagnostic measure & surgery.

Indication: Mild to moderate pain & fever.

Indication: Relief of fever & mild to moderate pain including headache, dental pain, post-op pain, dysmenorrhoea; musc...

Indication: Relief of fever & pain eg, headache, toothache, colds, flu, muscular rheumatism, dysmenorrhoea, teething p...

Indication: Relief of painful & febrile conditions eg, headache, migraine, backache, toothache, aches due to cold &...

Indication: Major depressive disorder, generalized anxiety disorder. Management of diabetic peripheral neuropathic pain.

Indication: Primary dysmenorrhea & relief of moderate pain when therapy will not exceed 1 wk.

Indication: Symptomatic relief of mild to moderate pain & fever.

Indication: Relief of mild to moderate pain & fever.

2  /  10
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 4 days ago
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.
01 Sep 2020
Acute diarrhoea is the second leading cause of deathin children aged younger than 5 years, accounting forapproximately 1.9 million deaths worldwide each year;however, diarrhoea is a preventable and treatable condition.In Malaysia, acute gastroenteritis accounts for about 1.3%of all deaths in children aged younger than 5 years annually.Diarrhoea is defined as the passage of three or more looseor watery stools within 24 hours, and it may be clinicallycategorised as either acute watery diarrhoea (AWD), acutebloody diarrhoea, persistent diarrhoea or diarrhoea withsevere malnutrition.